Patient: Lea Panagiotidis Lea, a college soccer player, shares her journey through ACL surgery and explains how a non-opioid pain management approach helped her get back on the field sooner
There are currently threeFDA-approved semaglutideproducts: As the world's first and currently onlyweekly glucagon-like peptid-1 receptor agonist (GLP-1RA) formulation forlong-term weight management, Semaglutideweight loss achieves an average weight loss of 17% (16.8kg) and providespatients with multiple health benefits beyond weight loss
Uhr et al., 2008)
In several studies, consistent decrease of SBP and BP-lowering occurred in the early period independent of weight loss (112114)
Common Symptoms of Low Sex Drive Women experiencing low libido may notice: Persistent low or absent sex drive Reduced arousal or responsiveness during intimacy Difficulty maintaining interest or engagement Decreased sexual satisfaction Changes in desire related to stress, aging, or hormonal shifts Loss of confidence connected to intimacy Key Benefits of PT-141 When prescribed and monitored by a SynergenX provider, PT-141 may help: Increase sexual desire and interest Improve arousal and responsiveness Enhance overall sexual satisfaction Support confidence and connection in intimate relationships A Peptide for Sex Drive That Works Differently PT-141 is a peptide for sex that targets melanocortin receptors in the brain, which play a key role in sexual desire
Research shows it modulates immune responses in the gut, strengthens intestinal barrier function, and influences the signaling environment around enteroendocrine cells, which include the L-cells that produce GLP-1